Malignant Ischemic Stroke
Malignant ischemic stroke is a severe type of stroke caused by a blockage in a large blood vessel in the brain, leading to significant brain damage and potentially life-threatening complications.
Acute Ischemic Stroke: Mechanical Thrombectomy Study
We are studying whether adding a mechanical procedure to standard treatment helps patients with acute ischemic stroke due to large vessel blockage. The trial also examines safety and quality of life for participants.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have a history of significant disability or cognitive impairment before this stroke?
- Are you currently pregnant or breastfeeding?
- Is your blood pressure higher than 185/110 mmHg right before the intervention?
- Do you have severe liver disease, such as cirrhosis or liver failure?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Szpital Uniwersytecki Nr 2 Im Dr Jana Biziela W Bydgoszczy
Klinika Neurologii
Bydgoszcz, Poland
Uniwersytecki Szpital Kliniczny Nr 4 W Lublinie
Klinika Neurologii
Lublin, Poland
Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
Klinika Neurologiczna
Praga Południe, Poland
Sponsor: Medical University Of Gdansk
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.